The liver is the largest organ in the body and a very essential organ in keeping the body functioning properly. Cirrhosis is the damage to the liver, with the development of scars in trying to fix the damage. Any person can develop cirrhosis when serious and extensive injury, with scars, are developed inside the liver. Some of the general features include loss of functioning hepatocellular mass, which may lead to jaundice, oedema, coagulopathy, and a variety of metabolic abnormalities, among others.
As per the American College of Gastroenterology, cirrhosis causes 26,000 deaths each year and is among the seventh leading cause of death in the United States. In Europe, cirrhosis has a large burden of the disease, as it accounts for more than 2% of deaths in this region. Hepatomegaly and hepatosplenomegaly are clinical signs observed during physical examination and liver function tests.
This report by Mordor Intelligence provides extensive insights of the current scenario and growth prospects of the market studied. Detailed graphical representations of the pipeline landscape, based on various phases and status of clinical trials across major regions of the world are provided, with data obtained from multiple sources. The report also comprises of a list of key sponsors having pipeline products for the concerned market.
The report will cover analysis on trails and information on key sponsors, companies, and researchers.
Our data collection team builds scientific research models, based on data sourced from various internal databases, primary and secondary researches, and in-house team of research experts. The pipeline assessment reports are generated, based on the information procured from various stakeholders, such as sponsors, clinical trial organizations, pharmaceutical companies, government bodies, trade agencies, industry journals, scientific literature databases, investor reports, press release statements, and several other sources. The data generated using secondary research and primary research are validated through discussions with industry KOL’s and C-suite executives. The data presented in the reports are continuously updated, to incorporate the most relevant and authentic information to our clients.
2. Research Methodology
3. Disease Epidemiology and Trends
4. Healthcare Expenditure and R&D Trends
5. Executive Summary
6. Clinical Trials Segmentation, by Phase
6.1 Phase-III Product Candidates
6.2 Phase-II Product Candidates
6.3 Phase-I Product Candidates
7. Clinical Trials, Segmentation, by Status
7.6 Other Statuses
8. Pipeline Therapeutic Assessment (Infographic Charts and Brief description)
8.1. By Clinical Phase and Molecule Type
8.2. By Clinical Phase and Route of Administration
8.3 By Sponsor/Collaborator/Institutions
8.4 By Geography
9. Market Updates
10. Key Sponsor Profiles
11. Sources and Disclaimer
12. About Mordor Intelligence